期刊文献+

甲磺酸托烷司琼预防化疗引起胃肠道反应的临床研究 被引量:3

Tropisetron mesylate in the prevention of chemotherapy-induced gastrointestinal reactions
原文传递
导出
摘要 目的 :比较甲磺酸托烷司琼和盐酸托烷司琼 (商品名 :欧必亭 )控制由顺铂、多柔比星 (阿霉素 )化疗所致胃肠道反应的疗效和不良反应。方法 :采用开放、随机自身交叉对照方法。 39例接受含顺铂和 (或 )多柔比星化疗的肿瘤患者随机进入AB ,BA组。AB组第 1周期化疗止吐给予甲磺酸托烷司琼 ,第 2周期给予盐酸托烷司琼 ;BA组则相反。同一患者接受的第 1 ,2周期化疗方案完全相同。结果 :入组患者中 ,9例未按试验要求完成观察 ,故可评价疗效患者 30例。A周期可评价不良反应 35例 ,B周期 36例。全组患者用甲磺酸托烷司琼后对食欲的影响 ,对恶心和呕吐的控制与盐酸托烷司琼相似 ,两组间差异无显著性 (均为P >0 .0 5 )。与两药可能相关的不良反应为轻度 ,均可耐受。结论 :国产甲磺酸托烷司琼治疗顺铂。 Objective:To compare the efficacy and side effects between tropisetron mesylate(TPTM) and tropisetron hydrochloride (TPTH) in prevention of chemotherapy_induced gastrointestinal reactions .Methods:Open, randomized self_cross over control trial was carried out. Thirty nine cancer patients who received chemotherapy containing cisplatin (DDP) and doxorubicin(adriamycin,ADM) were randomly divided into AB and BA study groups. The patients in AB group were treated with TPTM in the first cycle and TPTH in the second cycle, and those in BA group were treated with the two drugs in reverse order. Chemotherapy regimens were same in the first cycle and second cycle for one patient.Results:Nine patients were excluded because the observation protocol was not completed. Therefore efficacy could be evaluated in 30 patients.Adverse reactions were evaluated in 35 patients in A cycle and 36 patients in B cycle. The effectiveness of TPTM and TPTH was similar for the treatment of anorexia, nausea and vomiting ( P >0.05). Side reactions which may be drug_related were mild and also well tolerated in both groups.Conclusions:TPTM and TPTH are similar in the efficacy and side effects for the prevention of gastrointestinal reactions induced by chemotherapy containing DDP and ADM.
出处 《军事医学科学院院刊》 CSCD 北大核心 2003年第3期205-208,共4页 Bulletin of the Academy of Military Medical Sciences
关键词 药物疗法 甲磺酸托烷司琼 盐酸托烷司琼(欧必亭) 顺铂 多柔比星 胃肠道反应 恶心 呕吐 drug therapy tropisetron mesylate tropisetron hydrochloride cisplatin doxorubicin gastrointestinal reaction nausea vomiting
  • 相关文献

参考文献5

  • 1杨征,宋三泰,訾薇娜,江孝香,龚正华,罗质璞.国产甲磺酸托烷司琼正常人体耐受性试验[J].中国新药杂志,2001,10(5):367-370. 被引量:2
  • 2Morrow GR, Hickok JT, Rosenthal SN. Progress in reducing nausea and emesis.Comparison of ondansetron (Zofran),granisetron(Kytril), and tropisetron (Navoban)[J]. Cancer, 1995,76 (3):343- 357.
  • 3Leibundgut U, Lancranjan I. First results with ICS 205-930 (5HT3 receptor antagonist ) in prevention of chemotherapy-induced emesis[J].Lancet, 1987,1 (8543):1198.
  • 4Seinen H, Zonnenberg BA, Tjia P, et al. The effect of three dose levels of ICS 205-930 (a selective 5HT3 antagonist) on cisplatin-induced nausea and vomiting[J]. Ear J Cancer Clin Oncol, 1989,25 (9):1333- 1335.
  • 5Sorbe B. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience[J]. Ann Oncol, 1993,4(Suppl 3) :39 - 42.

二级参考文献1

共引文献1

同被引文献17

  • 1佟仲生,刘基巍,高亚杰,南克俊,李淑芬,汪旭,何丽红,王忱.国产托烷司琼治疗由顺铂引起恶心呕吐的临床观察[J].中国肿瘤临床,2005,32(14):824-826. 被引量:5
  • 2Sorbe BG, Hogberg T.Glimelius B. et al . A randomized,multi-center study comparing the efficacy and tolerability of tropisetron,a new 5-HT receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis[J]. Cancer , 1994,73(2) :445-454.
  • 3胡善联.敏感度分析[J].药物经济学系列讲座,2000,1:36.
  • 4Prestayko AW,D'Aoust JC,Issell BF,et al. Cisplatin (Cis-Diamminedichloroplatinum n ). Cancer Treat Rev, 1979;6:17.
  • 5Schmoll H J,Aapro M S,PoliBigeIli S,et al.Comparison of an aprepitant regimenwith a multiple day on dansetron regimen,both with dexamethasone,for antiemeticefficacy in high dose cisplatin treatment[J].Ann Oncol,2006; 17(6): 1000' 1006.
  • 6Herrington J D,Jaskiewicz A D,Song J. Randomized,placebo controlled.pilot studyevaluating aprepitant single dose plus palonosetron and dexamethasone for theprevention of acute and delayed chemotherapy induce nausea and vomiting [J].Cancer,2008; 112(9):2080-2087.
  • 7Narang V S,Fraga C,Kum ar N,et al. Dexamethasone increases expression andactivity of multidrug resistance transporters at the rat blood brain barrier[J].Am JPhysiol Cell Physiol,2008;295(2):440-450.
  • 8Lindley C,Goodin S.McCune J,et al.Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenicchemotherapyicomparison of ondansetron,prochlorperazine,and dexamethasone[J].Am J Clin 0ncol,2005;28 (3): 270-276.
  • 9郑卫平,陈仲伟,王启朋,江穗,冯航,肖汉耿,朱李军.昂丹司琼预防口腔癌含顺铂化疗方案所致呕吐的临床效果[J].中山大学学报(医学科学版),2006,27(B04):84-85. 被引量:3
  • 10李志强,徐建明,刘端祺,张贺龙,王宝成,张沂平,欧阳学农,陈正堂,陶敏,高亚杰,王岩,李晓玲,刘烈军.盐酸帕洛诺司琼预防中重度化疗致吐药引起恶心呕吐的Ⅱ期临床研究[J].临床肿瘤学杂志,2009,14(6):487-490. 被引量:36

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部